Does DESVENLAFAXINE Cause Mobility decreased? 16 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Mobility decreased have been filed in association with DESVENLAFAXINE (Desvenlafaxine Succinate). This represents 0.2% of all adverse event reports for DESVENLAFAXINE.
16
Reports of Mobility decreased with DESVENLAFAXINE
0.2%
of all DESVENLAFAXINE reports
0
Deaths
2
Hospitalizations
How Dangerous Is Mobility decreased From DESVENLAFAXINE?
Of the 16 reports, 2 (12.5%) required hospitalization.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DESVENLAFAXINE. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does DESVENLAFAXINE Cause?
Drug ineffective (1,576)
Anxiety (679)
Feeling abnormal (671)
Dizziness (605)
Nausea (575)
Headache (548)
Depression (542)
Withdrawal syndrome (530)
Malaise (512)
Insomnia (428)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which DESVENLAFAXINE Alternatives Have Lower Mobility decreased Risk?
DESVENLAFAXINE vs DETROL
DESVENLAFAXINE vs DEUCRAVACITINIB
DESVENLAFAXINE vs DEUTETRABENAZINE
DESVENLAFAXINE vs DEUTIVACAFTOR\TEZACAFTOR\VANZACAFTOR
DESVENLAFAXINE vs DEVICE